These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16915372)

  • 1. Eosinophilic tumor in a patient with bronchial asthma receiving pranlukast.
    Watanabe T; Iinuma Y; Naito S; Nitta K
    Eur J Pediatr; 2007 Feb; 166(2):183-4. PubMed ID: 16915372
    [No Abstract]   [Full Text] [Related]  

  • 2. [Churg-Strauss syndrome during corticosteroid tapering in a patient with bronchial asthma receiving pranlukast].
    Baba K; Niwa S; Yagi T; Sakakibara A; Kobayashi T; Matsumoto Y
    Arerugi; 2000 Jun; 49(6):512-5. PubMed ID: 10916890
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute interstitial pneumonia induced by ONO-1078 (pranlukast), a leukotriene receptor antagonist.
    Takahashi N; Iwanaga T; Aizawa H; Koto H; Watanabe K; Kishikawa R; Ikeda T; Shoji S; Nishima S; Hara N
    Intern Med; 2001 Aug; 40(8):791-4. PubMed ID: 11518127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fulminant eosinophilic endomyocarditis in an asthmatic patient treated with pranlukast after corticosteroid withdrawal.
    Hayashi S; Furuya S; Imamura H
    Heart; 2001 Sep; 86(3):E7. PubMed ID: 11514498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast.
    Kinoshita M; Shiraishi T; Koga T; Ayabe M; Rikimaru T; Oizumi K
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):534-5. PubMed ID: 10069892
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist.
    Grossman J; Faiferman I; Dubb JW; Tompson DJ; Busse W; Bronsky E; Montanaro A; Southern L; Tinkelman D
    J Asthma; 1997; 34(4):321-8. PubMed ID: 9250256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
    Horiguchi T; Tachikawa S; Kondo R; Miyazaki J; Shiga M; Hirose M; Kobayashi K; Hayashi N; Ohira D; Nasu T; Otake Y; Hata H
    Arzneimittelforschung; 2007; 57(2):87-91. PubMed ID: 17396618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of response to long-term treatment with Pranlukast in patients with bronchial asthma.
    Niitsuma T; Izawa J; Maruoka N; Nukaga M; Tsuji A; Okita M; Sakurai K; Morita S; Tsuyuguchi M; Matsumura Y; Hayashi T
    J Investig Allergol Clin Immunol; 2004; 14(4):284-91. PubMed ID: 15736713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Churg-Strauss syndrome after pranlukast treatment in a patient not receiving corticosteroids.
    Katsura T; Yoshida F; Takinishi Y
    Ann Intern Med; 2003 Sep; 139(5 Pt 1):386-7. PubMed ID: 12965953
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term follow-up of pulmonary function in bronchial asthma patients treated with pranlukast.
    Yanagawa H; Sugita A; Azuma M; Ogawa H; Kitamuro C; Yoneda K; Shinkawa K; Tani K; Sone S
    Lung; 2004; 182(1):51-8. PubMed ID: 14752672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pranlukast, a cysteinyl leukotriene antagonist, reduces serum eosinophil cationic protein levels in patients with asthma.
    Ishioka S; Hozawa S; Haruta Y; Hiyama K; Maeda A; Yamakido M
    Hiroshima J Med Sci; 1999 Dec; 48(4):105-10. PubMed ID: 10804983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma.
    Tomari S; Shimoda T; Kawano T; Mitsuta K; Obase Y; Fukushima C; Matsuse H; Kohno S
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):156-61. PubMed ID: 11527250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the combined effect of pranlukast during high-dose steroid inhalation.
    Horiguchi T; Tachikawa S; Kondo R; Miyazaki J; Sasaki Y; Banno K; Handa M
    Arzneimittelforschung; 2002; 52(11):813-6. PubMed ID: 12489251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antileukotrienes and Churg-Strauss syndrome].
    Guilpain P; Pagnoux C; Lhote F; Mouthon L; Guillevin L
    Presse Med; 2007 May; 36(5 Pt 2):890-4. PubMed ID: 17383148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of switching low-dose inhaled corticosteroid to pranlukast for step-down therapy in well-controlled patients with mild persistent asthma.
    Harada S; Harada N; Itoigawa Y; Katsura Y; Kasuga F; Ishimori A; Makino F; Ito J; Atsuta R; Takahashi K
    J Asthma; 2016; 53(2):207-12. PubMed ID: 26325232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation.
    Yasui H; Fujisawa T; Inui N; Kato M; Hashimoto D; Enomoto N; Nakamura Y; Shirai T; Suda T; Nakamura H; Chida K
    Respir Med; 2012 Apr; 106(4):508-14. PubMed ID: 22265857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pranlukast hydrate on airway hyperresponsiveness in non-asthmatic patients with Japanese cedar pollinosis.
    Sagara H; Yukawa T; Kashima R; Okada T; Fukuda T
    Allergol Int; 2009 Jun; 58(2):277-87. PubMed ID: 19390239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation before and after pranlukast administration with the QOL questionnaire (revised version 2001) for pediatric patients with bronchial asthma and their parents or caregivers].
    Kondo N; Teramoto T; Inoue R; Fukutomi O; Matsui E; Shinoda S; Watanabe M; Sakaguchi H; Aoki M; Morimoto W; Suzuki K; Ohnishi H; Takemoto Y; Tanaka Y; Asano T; Yoshikawa K; Nagase T; Hashimoto K; Fujita Y; Yamamoto Y; Ri A; Hirayama K
    Arerugi; 2002 May; 51(5):421-9. PubMed ID: 12087760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cough-variant asthma successfully treated with a peptide leukotriene receptor antagonist].
    Nishi K; Watanabe K; Ooka T; Fujimura M; Matsuda T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jan; 35(1):117-23. PubMed ID: 9071168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of a leukotriene antagonist, pranlukast hydrate, on exercise-induced asthma for 14 days].
    Suguro H; Majima T; Hattori T; Ichimura K; Hashimoto N; Horie T
    Arerugi; 2000 Aug; 49(8):646-52. PubMed ID: 11021016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.